name: Hemophilia B
creation_date: '2026-02-02T00:16:36Z'
updated_date: '2026-02-17T21:53:14Z'
category: Genetic
parents:
- Bleeding Disorder
- Coagulation Disorder
disease_term:
  preferred_term: hemophilia B
  term:
    id: MONDO:0010604
    label: hemophilia B
description: >-
  Hemophilia B is an X-linked bleeding disorder caused by factor IX deficiency.
pathophysiology:
- name: Factor IX Deficiency
  description: >-
    Deficiency of coagulation factor IX impairs intrinsic pathway function and
    leads to abnormal bleeding.
  evidence:
  - reference: PMID:23430394
    supports: SUPPORT
    snippet: "Hemophilia B is a recessive X-linked bleeding disorder characterized
      by deficiency of the coagulation factor IX (FIX)."
    explanation: The abstract identifies factor IX deficiency as the cause of
      hemophilia B.
phenotypes:
- name: Abnormal Bleeding
  category: Hematologic
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Abnormal bleeding
    term:
      id: HP:0001892
      label: Abnormal bleeding
  evidence:
  - reference: PMID:23430394
    supports: SUPPORT
    snippet: "Hemophilia B is a recessive X-linked bleeding disorder characterized
      by deficiency of the coagulation factor IX (FIX)."
    explanation: The abstract describes hemophilia B as a bleeding disorder.
treatments:
- name: Factor IX Replacement
  description: Plasma-derived or recombinant factor IX concentrates for
    on-demand or prophylactic therapy.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:23430394
    supports: SUPPORT
    snippet: "Hemophilia B treatment has improved greatly in the last 20 years with
      the introduction first of plasma-derived and then of recombinant FIX concentrates."
    explanation: The abstract notes factor IX concentrates as key treatment
      advances.
- name: Prophylactic Factor IX Replacement
  description: Regular prophylactic dosing to prevent bleeding and arthropathy.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:23430394
    supports: SUPPORT
    snippet: "Replacement therapy may be administered through on-demand or prophylaxis
      regimens, but the latter treatment modality has been shown to be superior in
      prevention of hemophilic arthropathy and in improvement of patients' quality
      of life."
    explanation: The abstract notes prophylaxis as a superior treatment modality
      for prevention of arthropathy.
  - reference: PMID:39950390
    supports: SUPPORT
    snippet: "Prophylaxis with coagulation factor concentrates is the mainstay of
      treatment in severe hemophilia A and B."
    explanation: The abstract describes prophylactic factor replacement as the
      mainstay of treatment for severe hemophilia.
references:
- reference: DOI:10.1002/14651858.cd014544.pub2
  title: Non-clotting factor therapies for preventing bleeds in people with
    congenital hemophilia A or B
  findings: []
- reference: DOI:10.1007/s13353-025-00952-w
  title: Gene therapy as an innovative approach to the treatment of hemophilia
    Bâ€”a review
  findings: []
- reference: DOI:10.1007/s40140-024-00635-y
  title: Perioperative Management of Hemophilia Patients
  findings: []
- reference: DOI:10.1056/nejmoa2302982
  title: Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B
  findings: []
- reference: DOI:10.1111/j.1365-2516.2005.01123.x
  title: 'Iliopsoas haemorrhage in patients with haemophilia: results from one centre'
  findings: []
- reference: DOI:10.1186/s13052-024-01819-2
  title: 'Intracranial hemorrhage in an infant leads to the diagnosis and treatment
    of severe hemophilia B: a case report'
  findings: []
- reference: DOI:10.14302/issn.2372-6601.jhor-24-5108
  title: 'Understanding Inherited Bleeding Disorders: Genetic Mutations in Blood Coagulation
    Factors and Regulatory Proteins'
  findings: []
- reference: DOI:10.3389/fmed.2025.1618464
  title: 'Therapeutic advances in hemophilia: from molecular innovation to patient-centered
    global care'
  findings: []
- reference: DOI:10.3390/biom14070854
  title: 'Recent Advances in Gene Therapy for Hemophilia: Projecting the Perspectives'
  findings: []
- reference: DOI:10.57582/ijbf.250502.066
  title: 'Hemophilia: changes and new achievements in management and care'
  findings: []
